Research Papers: Pathology:
Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs)
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2319 views | HTML 2224 views | ?
Laura Leone1, Salvatore Raffa1,4, Mario Vetrano2, Danilo Ranieri1, Florence Malisan3, Cristina Scrofani1, Maria Chiara Vulpiani2, Andrea Ferretti2, Maria Rosaria Torrisi1,4 and Vincenzo Visco1,4
1 Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, “Sapienza” University of Rome, Rome, Italy
2 Department of Orthopedics and Traumatology, Sant’Andrea Hospital, Faculty of Medicine and Psychology, “Sapienza” University of Rome, Rome, Italy
3 Department of Biomedicine and Prevention, Laboratory of Signal Transduction, “Tor Vergata” University of Rome, Rome, Italy
4 Cellular Diagnostics Unit, Sant’Andrea Hospital, Rome, Italy
Vincenzo Visco, email:
Keywords: differentiation, tendon, stem cells, healing, ESWT, Pathology Section
Received: August 03, 2015 Accepted: January 13, 2016 Published: January 28, 2016
Extracorporeal shock wave therapy (ESWT) is a non-invasive and innovative technology for the management of specific tendinopathies. In order to elucidate the ESWT-mediated clinical benefits, human Tendon-derived Stem/Progenitor cells (hTSPCs) explanted from 5 healthy semitendinosus (ST) and 5 ruptured Achilles (AT) tendons were established. While hTSPCs from the two groups showed similar proliferation rates and stem cell surface marker profiles, we found that the clonogenic potential was maintained only in cells derived from healthy donors. Interestingly, ESWT significantly accelerated hTSPCs differentiation, suggesting that the clinical benefits of ESWT may be ascribed to increased efficiency of tendon repair after injury.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.